CEP
EGRX

Chicago Equity Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Chicago Equity Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,135
Closed -$849K – 897
2019
Q4 		$849K Sell
14,135
-21,740
-61% -$1.31M 0.05% 508
2019
Q3 		$2.03M Buy
35,875
+20,075
+127% +$1.14M 0.1% 312
2019
Q2 		$880K Buy
+15,800
New +$880K 0.04% 557